Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.3.2 replaces Revision: v3.3.1 on the page; this is a minor UI/version label update and does not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedThe changes include an addition noting PubMed auto-fill for publications (which may not be about the study) and a deletion clarifying PubMed-originated publications automatically created by ClinicalTrials.gov using the NCT Number, with the revision updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study location listing was updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' by adding the new location and removing the older one. A funding notice banner was removed.SummaryDifference0.1%

- Check44 days agoChange DetectedExternal resource links at the bottom of the Study Details page were removed, including DailyMed, PubMed searches, vivli, and several government sites. This reduces quick access to supporting documents but does not change the core study information such as eligibility, design, outcomes, or locations.SummaryDifference0.2%

- Check73 days agoChange DetectedMajor update to version 3.2.0 accompanied by a government-status notice; removes the old v3.1.0 reference and adds operating-status details.SummaryDifference1%

- Check80 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0; new contact numbers added for support/hours.SummaryDifference0.0%

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.